BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 23376256)

  • 1. DNA mismatch repair protein MSH2 dictates cellular survival in response to low dose radiation in endometrial carcinoma cells.
    Martin LM; Marples B; Davies AM; Atzberger A; Edwards C; Lynch TH; Hollywood D; Marignol L
    Cancer Lett; 2013 Jul; 335(1):19-25. PubMed ID: 23376256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase.
    Franchitto A; Pichierri P; Piergentili R; Crescenzi M; Bignami M; Palitti F
    Oncogene; 2003 Apr; 22(14):2110-20. PubMed ID: 12687013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation.
    Yan T; Schupp JE; Hwang HS; Wagner MW; Berry SE; Strickfaden S; Veigl ML; Sedwick WD; Boothman DA; Kinsella TJ
    Cancer Res; 2001 Nov; 61(22):8290-7. PubMed ID: 11719462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of MRE11 loss on PARP-inhibitor sensitivity in endometrial cancer in vitro.
    Koppensteiner R; Samartzis EP; Noske A; von Teichman A; Dedes I; Gwerder M; Imesch P; Ikenberg K; Moch H; Fink D; Stucki M; Dedes KJ
    PLoS One; 2014; 9(6):e100041. PubMed ID: 24927325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose hyper-radiosensitivity is not caused by a failure to recognize DNA double-strand breaks.
    Wykes SM; Piasentin E; Joiner MC; Wilson GD; Marples B
    Radiat Res; 2006 May; 165(5):516-24. PubMed ID: 16669705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of MSH2 and MSH6 in cadmium-induced G2/M checkpoint arrest in Arabidopsis roots.
    Cao X; Wang H; Zhuang D; Zhu H; Du Y; Cheng Z; Cui W; Rogers HJ; Zhang Q; Jia C; Yang Y; Tai P; Xie F; Liu W
    Chemosphere; 2018 Jun; 201():586-594. PubMed ID: 29533809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose hyper-radiosensitivity in human hepatocellular HepG2 cells is associated with Cdc25C-mediated G2/M cell cycle checkpoint control.
    Xue J; Zong Y; Li PD; Wang LX; Li YQ; Niu YF
    Int J Radiat Biol; 2016 Oct; 92(10):543-7. PubMed ID: 27501010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival with an intact DNA mismatch repair system in endometrial cancer.
    Cohn DE; Frankel WL; Resnick KE; Zanagnolo VL; Copeland LJ; Hampel H; Kelbick N; Morrison CD; Fowler JM
    Obstet Gynecol; 2006 Nov; 108(5):1208-15. PubMed ID: 17077244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzo[a]pyrene represses DNA repair through altered E2F1/E2F4 function marking an early event in DNA damage-induced cellular senescence.
    Allmann S; Mayer L; Olma J; Kaina B; Hofmann TG; Tomicic MT; Christmann M
    Nucleic Acids Res; 2020 Dec; 48(21):12085-12101. PubMed ID: 33166399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of DNA mismatch repair protein in endometrial carcinomas and its correlation with clinicopathologic features].
    Bi R; Tu XY; Xiao YX; Shan BE; Wang HY; Cai X; Zhou XY; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2016 May; 45(5):302-7. PubMed ID: 27142910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemistry for mismatch repair protein deficiency in endometrioid endometrial carcinoma yields equivalent results when performed on endometrial biopsy/curettage or hysterectomy specimens.
    Chapel DB; Yamada SD; Cowan M; Lastra RR
    Gynecol Oncol; 2018 Jun; 149(3):570-574. PubMed ID: 29656794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An association between low-dose hyper-radiosensitivity and the early G2-phase checkpoint in normal fibroblasts of cancer patients.
    Słonina D; Gasińska A; Biesaga B; Janecka A; Kabat D
    DNA Repair (Amst); 2016 Mar; 39():41-5. PubMed ID: 26725161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation.
    Davis TW; Wilson-Van Patten C; Meyers M; Kunugi KA; Cuthill S; Reznikoff C; Garces C; Boland CR; Kinsella TJ; Fishel R; Boothman DA
    Cancer Res; 1998 Feb; 58(4):767-78. PubMed ID: 9485033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition in survival from low-dose hyper-radiosensitivity to increased radioresistance is independent of activation of ATM Ser1981 activity.
    Krueger SA; Collis SJ; Joiner MC; Wilson GD; Marples B
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1262-71. PubMed ID: 17967316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity to camptothecin in MSH2 deficient cells is correlated with a role for MSH2 protein in recombinational repair.
    Pichierri P; Franchitto A; Piergentili R; Colussi C; Palitti F
    Carcinogenesis; 2001 Nov; 22(11):1781-7. PubMed ID: 11698339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of G2-checkpoint dynamics on low-dose hyper-radiosensitivity.
    Olobatuyi O; de Vries G; Hillen T
    J Math Biol; 2018 Dec; 77(6-7):1969-1997. PubMed ID: 29679122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATM-dependent hyper-radiosensitivity in mammalian cells irradiated by heavy ions.
    Xue L; Yu D; Furusawa Y; Cao J; Okayasu R; Fan S
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):235-43. PubMed ID: 19695441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of O6MeG lesions by MGMT and mismatch repair proficiency may be a prerequisite for low-dose radiation hypersensitivity.
    Martin L; Marples B; Coffey M; Lawler M; Hollywood D; Marignol L
    Radiat Res; 2009 Oct; 172(4):405-13. PubMed ID: 19772461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining if low dose hyper-radiosensitivity (HRS) can be exploited to provide a therapeutic advantage: a cell line study in four glioblastoma multiforme (GBM) cell lines.
    Schoenherr D; Krueger SA; Martin L; Marignol L; Wilson GD; Marples B
    Int J Radiat Biol; 2013 Dec; 89(12):1009-16. PubMed ID: 23859266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.